Lemaitre Vascular Stock Net Income
| LMAT Stock | USD 84.80 0.48 0.56% |
As of the 27th of January, LeMaitre Vascular secures the mean deviation of 1.13, and Risk Adjusted Performance of (0.03). Concerning fundamental indicators, the technical analysis model lets you check available technical drivers of LeMaitre Vascular, as well as the relationship between them.
LeMaitre Vascular Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 7.3785 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 50.6 M | 53.2 M | |
| Net Income Applicable To Common Shares | 23.7 M | 24.9 M | |
| Net Income From Continuing Ops | 50.6 M | 53.2 M | |
| Net Income Per Share | 1.77 | 1.85 | |
| Net Income Per E B T | 0.89 | 0.92 |
LeMaitre | Net Income | Build AI portfolio with LeMaitre Stock |
Latest LeMaitre Vascular's Net Income Growth Pattern
Below is the plot of the Net Income of LeMaitre Vascular over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in LeMaitre Vascular financial statement analysis. It represents the amount of money remaining after all of LeMaitre Vascular operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is LeMaitre Vascular's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LeMaitre Vascular's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 44.04 M | 10 Years Trend |
|
Net Income |
| Timeline |
LeMaitre Net Income Regression Statistics
| Arithmetic Mean | 19,667,858 | |
| Coefficient Of Variation | 86.35 | |
| Mean Deviation | 13,214,791 | |
| Median | 17,934,000 | |
| Standard Deviation | 16,983,003 | |
| Sample Variance | 288.4T | |
| Range | 53.8M | |
| R-Value | 0.95 | |
| Mean Square Error | 31.8T | |
| R-Squared | 0.90 | |
| Slope | 3,184,846 | |
| Total Sum of Squares | 4614.8T |
LeMaitre Net Income History
Other Fundumenentals of LeMaitre Vascular
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
LeMaitre Vascular Net Income component correlations
LeMaitre Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for LeMaitre Vascular is extremely important. It helps to project a fair market value of LeMaitre Stock properly, considering its historical fundamentals such as Net Income. Since LeMaitre Vascular's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of LeMaitre Vascular's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of LeMaitre Vascular's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LeMaitre Vascular. If investors know LeMaitre will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LeMaitre Vascular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.536 | Dividend Share 0.76 | Earnings Share 2.32 | Revenue Per Share | Quarterly Revenue Growth 0.114 |
The market value of LeMaitre Vascular is measured differently than its book value, which is the value of LeMaitre that is recorded on the company's balance sheet. Investors also form their own opinion of LeMaitre Vascular's value that differs from its market value or its book value, called intrinsic value, which is LeMaitre Vascular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LeMaitre Vascular's market value can be influenced by many factors that don't directly affect LeMaitre Vascular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LeMaitre Vascular's value and its price as these two are different measures arrived at by different means. Investors typically determine if LeMaitre Vascular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LeMaitre Vascular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
LeMaitre Vascular 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to LeMaitre Vascular's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of LeMaitre Vascular.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in LeMaitre Vascular on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding LeMaitre Vascular or generate 0.0% return on investment in LeMaitre Vascular over 90 days. LeMaitre Vascular is related to or competes with Quidel, Acadia Healthcare, Haemonetics, AtriCure, Inspire Medical, Twist Bioscience, and Aveanna Healthcare. LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment o... More
LeMaitre Vascular Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure LeMaitre Vascular's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess LeMaitre Vascular upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 8.28 | |||
| Value At Risk | (2.30) | |||
| Potential Upside | 2.17 |
LeMaitre Vascular Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for LeMaitre Vascular's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as LeMaitre Vascular's standard deviation. In reality, there are many statistical measures that can use LeMaitre Vascular historical prices to predict the future LeMaitre Vascular's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.21) | |||
| Treynor Ratio | (0.1) |
LeMaitre Vascular January 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.09) | |||
| Mean Deviation | 1.13 | |||
| Coefficient Of Variation | (2,298) | |||
| Standard Deviation | 1.46 | |||
| Variance | 2.12 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.21) | |||
| Treynor Ratio | (0.1) | |||
| Maximum Drawdown | 8.28 | |||
| Value At Risk | (2.30) | |||
| Potential Upside | 2.17 | |||
| Skewness | 0.1163 | |||
| Kurtosis | 0.6455 |
LeMaitre Vascular Backtested Returns
LeMaitre Vascular has Sharpe Ratio of -0.0415, which conveys that the firm had a -0.0415 % return per unit of volatility over the last 3 months. LeMaitre Vascular exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify LeMaitre Vascular's mean deviation of 1.13, and Risk Adjusted Performance of (0.03) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.77, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, LeMaitre Vascular's returns are expected to increase less than the market. However, during the bear market, the loss of holding LeMaitre Vascular is expected to be smaller as well. At this point, LeMaitre Vascular has a negative expected return of -0.0622%. Please make sure to verify LeMaitre Vascular's variance, potential upside, as well as the relationship between the Potential Upside and day typical price , to decide if LeMaitre Vascular performance from the past will be repeated at some future point.
Auto-correlation | -0.66 |
Very good reverse predictability
LeMaitre Vascular has very good reverse predictability. Overlapping area represents the amount of predictability between LeMaitre Vascular time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of LeMaitre Vascular price movement. The serial correlation of -0.66 indicates that around 66.0% of current LeMaitre Vascular price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.66 | |
| Spearman Rank Test | -0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 2.75 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
LeMaitre Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, LeMaitre Vascular reported net income of 44.04 M. This is 87.1% lower than that of the Health Care Equipment & Supplies sector and 55.8% lower than that of the Health Care industry. The net income for all United States stocks is 92.29% higher than that of the company.
LeMaitre Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LeMaitre Vascular's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LeMaitre Vascular could also be used in its relative valuation, which is a method of valuing LeMaitre Vascular by comparing valuation metrics of similar companies.LeMaitre Vascular is currently under evaluation in net income category among its peers.
LeMaitre Vascular ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, LeMaitre Vascular's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to LeMaitre Vascular's managers, analysts, and investors.Environmental | Governance | Social |
LeMaitre Vascular Institutional Holders
Institutional Holdings refers to the ownership stake in LeMaitre Vascular that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of LeMaitre Vascular's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing LeMaitre Vascular's value.| Shares | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 408.6 K | Northern Trust Corp | 2025-06-30 | 343.2 K | Royal Bank Of Canada | 2025-06-30 | 311.6 K | Envestnet Asset Management Inc | 2025-06-30 | 304.6 K | Millennium Management Llc | 2025-06-30 | 290.3 K | Rockefeller Capital Management L.p. | 2025-06-30 | 289.5 K | T. Rowe Price Associates, Inc. | 2025-06-30 | 287.7 K | Acadian Asset Management Llc | 2025-06-30 | 257.4 K | Kayne Anderson Rudnick Investment Management Llc | 2025-06-30 | 243 K | Blackrock Inc | 2025-06-30 | 3.2 M | Conestoga Capital Advisors, Llc | 2025-06-30 | 1.6 M |
LeMaitre Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0794 | ||||
| Profit Margin | 0.22 % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | 1.78 B | ||||
| Shares Outstanding | 22.69 M | ||||
| Shares Owned By Insiders | 7.98 % | ||||
| Shares Owned By Institutions | 95.30 % | ||||
| Number Of Shares Shorted | 1.16 M | ||||
| Price To Earning | 38.99 X | ||||
| Price To Book | 5.11 X | ||||
| Price To Sales | 8.03 X | ||||
| Revenue | 219.86 M | ||||
| Gross Profit | 170.94 M | ||||
| EBITDA | 66.75 M | ||||
| Net Income | 44.04 M | ||||
| Cash And Equivalents | 75.68 M | ||||
| Cash Per Share | 3.45 X | ||||
| Total Debt | 185.69 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 6.34 X | ||||
| Book Value Per Share | 16.71 X | ||||
| Cash Flow From Operations | 44.12 M | ||||
| Short Ratio | 6.46 X | ||||
| Earnings Per Share | 2.32 X | ||||
| Price To Earnings To Growth | 1.85 X | ||||
| Target Price | 103.67 | ||||
| Number Of Employees | 651 | ||||
| Beta | 0.67 | ||||
| Market Capitalization | 1.93 B | ||||
| Total Asset | 551.82 M | ||||
| Retained Earnings | 145.09 M | ||||
| Working Capital | 371.58 M | ||||
| Current Asset | 58.18 M | ||||
| Current Liabilities | 10.37 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 0.93 % | ||||
| Net Asset | 551.82 M | ||||
| Last Dividend Paid | 0.76 |
About LeMaitre Vascular Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LeMaitre Vascular's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LeMaitre Vascular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LeMaitre Vascular based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for LeMaitre Stock Analysis
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.